HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Western and Central Africa  /  CAF

Central African Republic

The Central African Republic appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

96,000
People living with HIV, 2025
WHO Global Health Observatory
76.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$3k
United States HIV disbursements, 2026
ForeignAssistance.gov
$14.6m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$-10m$0$10m$20m$30m200220052008201120142017202020232026$14.6m$1k$14.4m$3k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $563k — — —
2003 $2.3m — $1.4m —
2004 $6.0m — $4.9m —
2005 $6.0m — $3.4m —
2006 $10.2m — $7.8m —
2007 $2.4m — $409k —
2008 $18.7m — $15.5m —
2009 $4.5m — $2.4m —
2010 $10.4m $44k $6.1m $4k
2011 $8.5m — $5.6m $375k
2012 $5.1m $64k $2.7m $372k
2013 $7.4m — $5.0m $57k
2014 $5.9m $1k $4.7m $1k
2015 $2.1m — — —
2016 $3.0m — — —
2017 $2.0m — — —
2018 $260k — — —
2019 $625k — — $-662k
2020 $16.6m — $16.3m —
2021 $14.3m — $13.7m —
2022 $22.4m — $22.2m $86k
2023 $35.6m — $35.2m $243k
2024 $14.6m — $14.4m $250k
2025 — — — $100k
2026 — — — $3k

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
0100k200k200020032006200920122015201820212024100,00067,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 160,000 130,000 190,000 —
2001 160,000 140,000 190,000 —
2002 160,000 140,000 190,000 —
2003 160,000 140,000 190,000 —
2004 160,000 130,000 180,000 —
2005 150,000 130,000 180,000 —
2006 150,000 130,000 170,000 —
2007 150,000 130,000 170,000 —
2008 150,000 120,000 170,000 —
2009 140,000 120,000 160,000 —
2010 140,000 120,000 160,000 15,000
2011 140,000 120,000 150,000 14,000
2012 130,000 110,000 150,000 17,000
2013 120,000 100,000 140,000 17,000
2014 120,000 97,000 130,000 24,000
2015 110,000 94,000 130,000 27,000
2016 110,000 91,000 130,000 32,000
2017 110,000 89,000 130,000 37,000
2018 110,000 87,000 130,000 40,000
2019 100,000 86,000 130,000 47,000
2020 100,000 85,000 130,000 51,000
2021 100,000 83,000 130,000 56,000
2022 100,000 81,000 130,000 61,000
2023 100,000 80,000 130,000 64,000
2024 100,000 79,000 130,000 67,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%25%50%75%2010201220142016201820202022202485.0%66.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 84.0% 11.0%
2011 82.0% 11.0%
2012 79.0% 13.0%
2013 77.0% 13.0%
2014 76.0% 21.0%
2015 74.0% 24.0%
2016 73.0% 29.0%
2017 74.0% 34.0%
2018 77.0% 37.0%
2019 78.0% 45.0%
2020 80.0% 49.0%
2021 81.0% 55.0%
2022 88.0% 60.0%
2023 85.0% 63.0%
2024 85.0% 66.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Central African Republic

2,925 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 779 27 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 247 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 160 17 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 60 9 2017–2025 fetch.theglobalfund.org 2026-10-12
IATI, through d-portal Expenditure account 55 3 2000–2026 d-portal.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 53 13 2016–2024 hivfinancial.unaids.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 43 3 2002–2024 sdmx.oecd.org 2026-10-12
WHO Global Health Expenditure Database Expenditure account 35 7 2015–2019 apps.who.int 2026-10-12
WHO HIV testing services dashboard Programme record 26 5 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
ForeignAssistance.gov Expenditure account 22 2 2010–2026 foreignassistance.gov 2026-10-29
UNAIDS Data 2025 country databook Expenditure account 14 3 2016–2022 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

74 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $51k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $51k (2025)
Country-reported HIV expenditure, all sources Financing USD 11 2016–2024 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $10.4m (2024)
Domestic funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $662k (2024)
Domestic public HIV expenditure Financing USD 10 2016–2022 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $2.5m (2022)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $7.2m (2025)
Expected USAID funding for the national TB programme Financing USD 7 2019–2025 WHO Global Tuberculosis Programme $20k (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $362k (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $41k (2025)
External HIV and STD spending, national health accounts Financing USD 5 2015–2019 WHO Global Health Expenditure Database $4.9m (2019)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $14.6m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 16 2000–2026 IATI, through d-portal $241k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $473k (2026)
External HIV financing from the United States (ODA) Financing USD 14 2010–2026 ForeignAssistance.gov, OECD Creditor Reporting System $3k (2026)
Funding received for collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $51k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 53,323,925 (2026)
Global Fund HIV disbursements to the country Financing USD 45 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $3.8m (2026)
Global Fund funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $9.3m (2024)
Government HIV and STD spending as a share of government health spending Financing percent 5 2015–2019 WHO Global Health Expenditure Database 2.3% (2019)
Government HIV and STD spending, national health accounts Financing USD 5 2015–2019 WHO Global Health Expenditure Database $438k (2019)
HIV and STD spending as a share of all external health spending Financing percent 5 2015–2019 WHO Global Health Expenditure Database 9.9% (2019)
HIV and STD spending as a share of all health spending Financing percent 5 2015–2019 WHO Global Health Expenditure Database 4.5% (2019)
HIV and STD spending, national health accounts Financing USD 5 2015–2019 WHO Global Health Expenditure Database $7.9m (2019)
HIV spending on TB/HIV co-infection Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $105k (2024)
HIV spending on critical enablers Financing USD 4 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $15k (2024)
HIV spending on governance and sustainability Financing USD 5 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $1.2m (2024)
HIV spending on prevention Financing USD 4 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $283k (2024)
HIV spending on prevention of vertical transmission Financing USD 2 2021–2024 UNAIDS Global AIDS Monitoring expenditure database $3.4m (2024)
HIV spending on treatment, care and support Financing USD 6 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $5.3m (2024)
International HIV expenditure (country-reported) Financing USD 11 2016–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $10.4m (2024)
Other bilateral HIV expenditure (country-reported) Financing USD 3 2016–2018 UNAIDS Global AIDS Monitoring expenditure database $191k (2018)
Out-of-pocket HIV expenditure by households Financing USD 3 2016–2018 UNAIDS Global AIDS Monitoring expenditure database $75k (2018)
Private HIV and STD spending, national health accounts Financing USD 5 2015–2019 WHO Global Health Expenditure Database $2.6m (2019)
Private HIV expenditure (country-reported) Financing USD 8 2016–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $28k (2021)
US HIV disbursements managed by other US agencies Financing USD 11 2010–2026 ForeignAssistance.gov $3k (2026)
USAID funding received by the national TB programme Financing USD 6 2018–2024 WHO Global Tuberculosis Programme $357k (2024)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 69 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 76.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 28 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 81.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 14 2009–2024 UNAIDS AIDSinfo 56.0% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2019–2023 UNAIDS AIDSinfo 1.6% (2023)
% of people living with HIV on ART who completed a course of TB preventive therapy Treatment cascade percent 1 2019 UNAIDS AIDSinfo 87.5% (2019)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 5 2013–2024 UNAIDS AIDSinfo 34.0% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2017–2024 UNAIDS AIDSinfo 57.2% (2024)
% of returned HIV test results that were positive Treatment cascade percent 25 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 5.6% (2024)
HIV self-test kits distributed Treatment cascade count 1 2024 WHO HIV testing services dashboard 1,467 (2024)
HIV tests performed at a health facility Treatment cascade count 3 2018–2024 WHO HIV testing services dashboard 361,025 (2024)
HIV tests performed through community outreach Treatment cascade count 1 2018 WHO HIV testing services dashboard 42,115 (2018)
HIV tests performed with the result returned to the person Treatment cascade count 27 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 361,025 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 14 2010–2024 UNAIDS AIDSinfo 40.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 16 2016–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 2,828 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 10 2021–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 1 2020 UNAIDS AIDSinfo 13.0% (2020)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 76 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 73,017 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 81.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 5 2017–2024 Global Fund Data Service 3,351 (2024)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 6 2019–2024 Global Fund Data Service 2,309 (2024)
People newly enrolled on ART during the year Treatment cascade count 7 2013–2024 WHO Global Tuberculosis Programme 8,269 (2024)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 9 2015–2024 UNAIDS AIDSinfo 68.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 39 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 8,047 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 2,872 (2024)
TB patients with an HIV test result recorded Treatment cascade count 15 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 12,709 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,800 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 1,500 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 2.4% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 5,100 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,800 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 96,000 (2025)
Key-population people reached by outreach (count over the period) Prevention and outreach count 10 2021–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 3 2019–2024 UNAIDS AIDSinfo 29,083,040 (2024)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 9,900 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 5,513,282 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 13.0% (2025)

Every row shown on the Central African Republic page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.